Literature DB >> 20656030

Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: the cognitive reserve theory.

Julien Dumurgier1, Claire Paquet, Sarah Benisty, Claire Kiffel, Claude Lidy, François Mouton-Liger, Hugues Chabriat, Jean-Louis Laplanche, Jacques Hugon.   

Abstract

In Alzheimer's disease (AD), the cognitive reserve theory predicts that at any level of assessed clinical severity, the underlying brain pathology is more advanced in patients with more cognitive reserve. Recent evidences suggest that cerebrospinal fluid (CSF) biomarkers may reflect the brain pathology in AD. We investigated the relationship between education level and CSF concentrations of β-amyloid, total tau and phosphorylated tau (ptau-181) in a cohort of 70 subjects newly diagnosed with AD. We report that CSF concentration of β-amyloid was inversely associated with years of education, after adjustment for age, sex, and severity of the disease. We further demonstrate in stratified analysis that this relation was mainly present in mild form of the disease (CDR1), and was attenuated in more advanced forms of the disease. These results are consistent with the cognitive reserve theory, and suggest that cognitive reserve may be protective against amyloid related cognitive impairment at the onset of the clinical dementia.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20656030     DOI: 10.1016/j.nbd.2010.07.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  11 in total

1.  Effects of cognitive reserve depend on executive and semantic demands of the task.

Authors:  R Ryan Darby; Michael Brickhouse; David A Wolk; Bradford C Dickerson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-06-19       Impact factor: 10.154

Review 2.  Defining Cognitive Reserve and Implications for Cognitive Aging.

Authors:  Corinne Pettigrew; Anja Soldan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-01-09       Impact factor: 5.081

Review 3.  CSF biomarkers for amyloid and tau pathology in Alzheimer's disease.

Authors:  Hanna Rosenmann
Journal:  J Mol Neurosci       Date:  2011-11-05       Impact factor: 3.444

4.  Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.

Authors:  Julien Dumurgier; Bernard J Hanseeuw; Frances B Hatling; Kelly A Judge; Aaron P Schultz; Jasmeer P Chhatwal; Deborah Blacker; Reisa A Sperling; Keith A Johnson; Bradley T Hyman; Teresa Gómez-Isla
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease.

Authors:  Anja Soldan; Corinne Pettigrew; Shanshan Li; Mei-Cheng Wang; Abhay Moghekar; Ola A Selnes; Marilyn Albert; Richard O'Brien
Journal:  Neurobiol Aging       Date:  2013-08-01       Impact factor: 4.673

Review 6.  Cognitive Reserve from the Perspective of Preclinical Alzheimer Disease: 2020 Update.

Authors:  Anja Soldan; Corinne Pettigrew; Marilyn Albert
Journal:  Clin Geriatr Med       Date:  2019-11-15       Impact factor: 3.076

Review 7.  Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease.

Authors:  Anja Soldan; Corinne Pettigrew; Marilyn Albert
Journal:  Psychiatr Clin North Am       Date:  2017-12-07

8.  Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.

Authors:  Prashanthi Vemuri; Stephen D Weigand; Scott A Przybelski; David S Knopman; Glenn E Smith; John Q Trojanowski; Leslie M Shaw; Charlie S Decarli; Owen Carmichael; Matt A Bernstein; Paul S Aisen; Michael Weiner; Ronald C Petersen; Clifford R Jack
Journal:  Brain       Date:  2011-04-07       Impact factor: 13.501

9.  Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease.

Authors:  Julien Dumurgier; Francois Mouton-Liger; Pauline Lapalus; Magali Prevot; Jean-Louis Laplanche; Jacques Hugon; Claire Paquet
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

Review 10.  Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.

Authors:  Benjamin Lam; Mario Masellis; Morris Freedman; Donald T Stuss; Sandra E Black
Journal:  Alzheimers Res Ther       Date:  2013-01-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.